부신피질 호르몬 API : 세계 시장 점유율과 순위, 천체 판매 및 수요 예측(2025-2031년)

The global market for Adrenocortical Hormones API was estimated to be worth US$ 2580 million in 2024 and is forecast to a readjusted size of US$ 3892 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Adrenocortical hormones active pharmaceutical ingredients (APIs) refer to the raw materials used in the production of corticosteroid drugs. These hormones are synthesized in the adrenal cortex and play a crucial role in regulating metabolism, immune response, and stress adaptation. Common adrenocortical hormone APIs include hydrocortisone, prednisone, dexamethasone, and betamethasone, which are widely used in the treatment of inflammatory diseases, autoimmune disorders, and endocrine dysfunctions. The production of these APIs involves complex chemical synthesis or semi-synthetic processes derived from steroid precursors, often sourced from plant sterols. Due to their essential medical applications, adrenocortical hormone APIs are subject to strict quality control and regulatory compliance to ensure their efficacy and safety.

Adrenocortical hormone drugs are widely used for anti-inflammatory, immunosuppressive, and endocrine disease treatments, with stable and growing market demand. Historically, the global steroid drug industry has been dominated by major multinational pharmaceutical companies from Europe and the United States, such as Pfizer, Bayer, Merck, and Sanofi. These companies hold key technologies and have a strong presence in high-end markets. However, in recent years, China has emerged as a major production hub for steroid drugs due to its advantages in raw material supply, lower production costs, and continuous improvements in manufacturing technology. As a result, China has become an increasingly significant player in the global adrenocortical hormone API market.As the pharmaceutical industry continues to globalize, the supply chain for steroid drugs is becoming more optimized. Chinese manufacturers are advancing in industrial upgrading and quality control, driving the sector towards greater standardization and higher value-added products. Additionally, stricter environmental regulations and improved production standards are pushing companies toward green manufacturing and better compliance management, further strengthening China's competitiveness in the global market. Moreover, rising aging populations and increasing prevalence of chronic diseases worldwide are expected to sustain demand for adrenocortical hormone drugs, creating further growth opportunities for the industry.Several factors are driving the industry's growth. Firstly, breakthroughs in fermentation and chemical synthesis technologies have lowered production costs, enhancing global competitiveness. Secondly, Chinese manufacturers have made significant progress in quality control and international certifications, enabling easier entry into high-end markets in Europe and the United States. Additionally, multinational pharmaceutical companies are increasingly relying on Chinese suppliers to optimize their production costs and supply chain efficiency, accelerating the industry's shift toward China.However, the industry also faces challenges. Stricter environmental regulations worldwide are increasing operational costs for some manufacturers. Additionally, changes in international trade policies and intellectual property rights protection could impact Chinese companies' export competitiveness. Furthermore, technical barriers in high-end markets remain, requiring Chinese companies to further invest in core patents, brand influence, and premium product development.

This report aims to provide a comprehensive presentation of the global market for Adrenocortical Hormones API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Adrenocortical Hormones API by region & country, by Type, and by Application.

The Adrenocortical Hormones API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adrenocortical Hormones API.

Market Segmentation

By Company

• Pfizer CentreOne
• EUROAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid SpA
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab
• Sun Pharmaceutical
• Cipla
• Wellona Pharma
• Tianjin Tianyao Pharmaceuticals
• Zhejiang Xianju Pharmaceutical
• Guangdong Vtr Bio-Tech
• Zhejiang Xianju Xianle Pharmaceutical
• TIANJIN PACIFIC PHARMACEUTICAL
• Shandong Xinhua Pharmaceutica Group
• Jiangsu Lianhuan Pharmaceutical
• Shanghai New Hualian Pharmaceutical
• Shandong Taihua Biotech
• Saituo Biological Technology
• Zhejiang Xianju Junye Pharmaceutical

Segment by Type

• Prednisone Series
• Dexamethasone Series
• Betamethasone Series
• Hydrocortisone Series
• Others

Segment by Application

• Injectable Drugs
• Oral Drugs
• Topical Drugs
• Inhaled Drugs

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Adrenocortical Hormones API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Adrenocortical Hormones API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Adrenocortical Hormones API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Adrenocortical Hormones API Product Introduction
• 1.2 Global Adrenocortical Hormones API Market Size Forecast
  • 1.2.1 Global Adrenocortical Hormones API Sales Value (2020-2031)
  • 1.2.2 Global Adrenocortical Hormones API Sales Volume (2020-2031)
  • 1.2.3 Global Adrenocortical Hormones API Sales Price (2020-2031)
• 1.3 Adrenocortical Hormones API Market Trends & Drivers
  • 1.3.1 Adrenocortical Hormones API Industry Trends
  • 1.3.2 Adrenocortical Hormones API Market Drivers & Opportunity
  • 1.3.3 Adrenocortical Hormones API Market Challenges
  • 1.3.4 Adrenocortical Hormones API Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Adrenocortical Hormones API Players Revenue Ranking (2024)
• 2.2 Global Adrenocortical Hormones API Revenue by Company (2020-2025)
• 2.3 Global Adrenocortical Hormones API Players Sales Volume Ranking (2024)
• 2.4 Global Adrenocortical Hormones API Sales Volume by Company Players (2020-2025)
• 2.5 Global Adrenocortical Hormones API Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Adrenocortical Hormones API Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Adrenocortical Hormones API Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Adrenocortical Hormones API
• 2.9 Adrenocortical Hormones API Market Competitive Analysis
  • 2.9.1 Adrenocortical Hormones API Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Adrenocortical Hormones API Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Prednisone Series
  • 3.1.2 Dexamethasone Series
  • 3.1.3 Betamethasone Series
  • 3.1.4 Hydrocortisone Series
  • 3.1.5 Others
• 3.2 Global Adrenocortical Hormones API Sales Value by Type
  • 3.2.1 Global Adrenocortical Hormones API Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Adrenocortical Hormones API Sales Value, by Type (2020-2031)
  • 3.2.3 Global Adrenocortical Hormones API Sales Value, by Type (%) (2020-2031)
• 3.3 Global Adrenocortical Hormones API Sales Volume by Type
  • 3.3.1 Global Adrenocortical Hormones API Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Adrenocortical Hormones API Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Adrenocortical Hormones API Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Adrenocortical Hormones API Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Injectable Drugs
  • 4.1.2 Oral Drugs
  • 4.1.3 Topical Drugs
  • 4.1.4 Inhaled Drugs
• 4.2 Global Adrenocortical Hormones API Sales Value by Application
  • 4.2.1 Global Adrenocortical Hormones API Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Adrenocortical Hormones API Sales Value, by Application (2020-2031)
  • 4.2.3 Global Adrenocortical Hormones API Sales Value, by Application (%) (2020-2031)
• 4.3 Global Adrenocortical Hormones API Sales Volume by Application
  • 4.3.1 Global Adrenocortical Hormones API Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Adrenocortical Hormones API Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Adrenocortical Hormones API Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Adrenocortical Hormones API Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Adrenocortical Hormones API Sales Value by Region
  • 5.1.1 Global Adrenocortical Hormones API Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Adrenocortical Hormones API Sales Value by Region (2020-2025)
  • 5.1.3 Global Adrenocortical Hormones API Sales Value by Region (2026-2031)
  • 5.1.4 Global Adrenocortical Hormones API Sales Value by Region (%), (2020-2031)
• 5.2 Global Adrenocortical Hormones API Sales Volume by Region
  • 5.2.1 Global Adrenocortical Hormones API Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Adrenocortical Hormones API Sales Volume by Region (2020-2025)
  • 5.2.3 Global Adrenocortical Hormones API Sales Volume by Region (2026-2031)
  • 5.2.4 Global Adrenocortical Hormones API Sales Volume by Region (%), (2020-2031)
• 5.3 Global Adrenocortical Hormones API Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Adrenocortical Hormones API Sales Value, 2020-2031
  • 5.4.2 North America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
  • 5.5.2 Europe Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Adrenocortical Hormones API Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Adrenocortical Hormones API Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Adrenocortical Hormones API Sales Value, 2020-2031
  • 5.7.2 South America Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Adrenocortical Hormones API Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Adrenocortical Hormones API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Adrenocortical Hormones API Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Adrenocortical Hormones API Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Adrenocortical Hormones API Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.3.2 United States Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.4.2 Europe Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.5.2 China Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.6.2 Japan Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.7.2 South Korea Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Adrenocortical Hormones API Sales Value, 2020-2031
  • 6.9.2 India Adrenocortical Hormones API Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Adrenocortical Hormones API Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Pfizer CentreOne
  • 7.1.1 Pfizer CentreOne Company Information
  • 7.1.2 Pfizer CentreOne Introduction and Business Overview
  • 7.1.3 Pfizer CentreOne Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Pfizer CentreOne Adrenocortical Hormones API Product Offerings
  • 7.1.5 Pfizer CentreOne Recent Development
• 7.2 EUROAPI
  • 7.2.1 EUROAPI Company Information
  • 7.2.2 EUROAPI Introduction and Business Overview
  • 7.2.3 EUROAPI Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 EUROAPI Adrenocortical Hormones API Product Offerings
  • 7.2.5 EUROAPI Recent Development
• 7.3 GlaxoSmithKline
  • 7.3.1 GlaxoSmithKline Company Information
  • 7.3.2 GlaxoSmithKline Introduction and Business Overview
  • 7.3.3 GlaxoSmithKline Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 GlaxoSmithKline Adrenocortical Hormones API Product Offerings
  • 7.3.5 GlaxoSmithKline Recent Development
• 7.4 Teva Pharmaceutical Industries
  • 7.4.1 Teva Pharmaceutical Industries Company Information
  • 7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
  • 7.4.3 Teva Pharmaceutical Industries Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Teva Pharmaceutical Industries Adrenocortical Hormones API Product Offerings
  • 7.4.5 Teva Pharmaceutical Industries Recent Development
• 7.5 Hovione
  • 7.5.1 Hovione Company Information
  • 7.5.2 Hovione Introduction and Business Overview
  • 7.5.3 Hovione Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Hovione Adrenocortical Hormones API Product Offerings
  • 7.5.5 Hovione Recent Development
• 7.6 Axplora
  • 7.6.1 Axplora Company Information
  • 7.6.2 Axplora Introduction and Business Overview
  • 7.6.3 Axplora Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Axplora Adrenocortical Hormones API Product Offerings
  • 7.6.5 Axplora Recent Development
• 7.7 Steroid SpA
  • 7.7.1 Steroid SpA Company Information
  • 7.7.2 Steroid SpA Introduction and Business Overview
  • 7.7.3 Steroid SpA Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Steroid SpA Adrenocortical Hormones API Product Offerings
  • 7.7.5 Steroid SpA Recent Development
• 7.8 Avik Pharmaceutical
  • 7.8.1 Avik Pharmaceutical Company Information
  • 7.8.2 Avik Pharmaceutical Introduction and Business Overview
  • 7.8.3 Avik Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Avik Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.8.5 Avik Pharmaceutical Recent Development
• 7.9 Anuh Pharma
  • 7.9.1 Anuh Pharma Company Information
  • 7.9.2 Anuh Pharma Introduction and Business Overview
  • 7.9.3 Anuh Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Anuh Pharma Adrenocortical Hormones API Product Offerings
  • 7.9.5 Anuh Pharma Recent Development
• 7.10 Symbiotec Pharmalab
  • 7.10.1 Symbiotec Pharmalab Company Information
  • 7.10.2 Symbiotec Pharmalab Introduction and Business Overview
  • 7.10.3 Symbiotec Pharmalab Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Symbiotec Pharmalab Adrenocortical Hormones API Product Offerings
  • 7.10.5 Symbiotec Pharmalab Recent Development
• 7.11 Sun Pharmaceutical
  • 7.11.1 Sun Pharmaceutical Company Information
  • 7.11.2 Sun Pharmaceutical Introduction and Business Overview
  • 7.11.3 Sun Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Sun Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.11.5 Sun Pharmaceutical Recent Development
• 7.12 Cipla
  • 7.12.1 Cipla Company Information
  • 7.12.2 Cipla Introduction and Business Overview
  • 7.12.3 Cipla Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Cipla Adrenocortical Hormones API Product Offerings
  • 7.12.5 Cipla Recent Development
• 7.13 Wellona Pharma
  • 7.13.1 Wellona Pharma Company Information
  • 7.13.2 Wellona Pharma Introduction and Business Overview
  • 7.13.3 Wellona Pharma Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Wellona Pharma Adrenocortical Hormones API Product Offerings
  • 7.13.5 Wellona Pharma Recent Development
• 7.14 Tianjin Tianyao Pharmaceuticals
  • 7.14.1 Tianjin Tianyao Pharmaceuticals Company Information
  • 7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
  • 7.14.3 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Offerings
  • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development
• 7.15 Zhejiang Xianju Pharmaceutical
  • 7.15.1 Zhejiang Xianju Pharmaceutical Company Information
  • 7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
  • 7.15.3 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Development
• 7.16 Guangdong Vtr Bio-Tech
  • 7.16.1 Guangdong Vtr Bio-Tech Company Information
  • 7.16.2 Guangdong Vtr Bio-Tech Introduction and Business Overview
  • 7.16.3 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Offerings
  • 7.16.5 Guangdong Vtr Bio-Tech Recent Development
• 7.17 Zhejiang Xianju Xianle Pharmaceutical
  • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
  • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
  • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development
• 7.18 TIANJIN PACIFIC PHARMACEUTICAL
  • 7.18.1 TIANJIN PACIFIC PHARMACEUTICAL Company Information
  • 7.18.2 TIANJIN PACIFIC PHARMACEUTICAL Introduction and Business Overview
  • 7.18.3 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Offerings
  • 7.18.5 TIANJIN PACIFIC PHARMACEUTICAL Recent Development
• 7.19 Shandong Xinhua Pharmaceutica Group
  • 7.19.1 Shandong Xinhua Pharmaceutica Group Company Information
  • 7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
  • 7.19.3 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Offerings
  • 7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development
• 7.20 Jiangsu Lianhuan Pharmaceutical
  • 7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
  • 7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
  • 7.20.3 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development
• 7.21 Shanghai New Hualian Pharmaceutical
  • 7.21.1 Shanghai New Hualian Pharmaceutical Company Information
  • 7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview
  • 7.21.3 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.21.5 Shanghai New Hualian Pharmaceutical Recent Development
• 7.22 Shandong Taihua Biotech
  • 7.22.1 Shandong Taihua Biotech Company Information
  • 7.22.2 Shandong Taihua Biotech Introduction and Business Overview
  • 7.22.3 Shandong Taihua Biotech Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.22.4 Shandong Taihua Biotech Adrenocortical Hormones API Product Offerings
  • 7.22.5 Shandong Taihua Biotech Recent Development
• 7.23 Saituo Biological Technology
  • 7.23.1 Saituo Biological Technology Company Information
  • 7.23.2 Saituo Biological Technology Introduction and Business Overview
  • 7.23.3 Saituo Biological Technology Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.23.4 Saituo Biological Technology Adrenocortical Hormones API Product Offerings
  • 7.23.5 Saituo Biological Technology Recent Development
• 7.24 Zhejiang Xianju Junye Pharmaceutical
  • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
  • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
  • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Offerings
  • 7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

• 8.1 Adrenocortical Hormones API Industrial Chain
• 8.2 Adrenocortical Hormones API Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Adrenocortical Hormones API Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Adrenocortical Hormones API Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer